Link Pharma Chem Reports Mixed Financial Results Amidst Operational Gains and Sales Decline in August 2025
Link Pharma Chem has announced its financial results for the quarter ending June 2025, showcasing significant improvements in operating profit, profit before tax, and profit after tax, all reaching their highest levels in five quarters. However, net sales experienced a decline, indicating mixed performance overall.
Link Pharma Chem, a microcap company in the commodity chemicals industry, has recently reported its financial results for the quarter ending June 2025. The results, declared on August 1, 2025, indicate a notable shift in the company's evaluation, with the score moving to 2 from -6 over the past three months.The financial data reveals several positive developments for Link Pharma Chem. The operating profit (PBDIT) reached Rs 0.64 crore, marking the highest figure in the last five quarters, suggesting a favorable near-term trend. Similarly, profit before tax (PBT) also peaked at Rs 0.30 crore, and profit after tax (PAT) reached Rs 0.40 crore, both representing the best performances in the same five-quarter span. Additionally, earnings per share (EPS) improved to Rs 0.90, reflecting enhanced profitability for shareholders.
Conversely, the company faced challenges in net sales, which totaled Rs 19.60 crore for the nine-month period, showing a year-on-year decline of 21.03%. This aspect indicates a negative trend in sales performance.
Overall, Link Pharma Chem's recent financial results highlight a complex landscape of both positive operational metrics and sales challenges.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
